Stillcanna Set to Begin Extracting its 2019 Harvest in Q4
VANCOUVER, BC / ACCESSSWIRE / August 12, 2019 / Stillcanna Inc. (OTC PINK:SCNNF) (CSE:STIL)(FRANKFURT:A2PEWA) ("STIL" or the "Company") is pleased to announce that it is in the final stages of preparing its Nexus building and expects to receive its extraction equipment within the next two weeks.
The Company’s new Nexus building is days away from completion, and its proprietary engineered extraction system due to arrive within 14 days. Shae de Jaray the Company’s COO and Chief Engineer, along with a specially trained installation team will be on the ground to begin final equipment assembly in late August. The Company anticipates being in CBD production in Q4 to meet its current contracts for CBD Isolate.
In conjunction with the completion of the Nexus facility, and the ongoing 2019 harvest, the Company intends to begin using its custom built drying technology this week in preparing its hemp flower for extraction.
“These are exciting times for Stillcanna,” explained Jason Dussault, CEO of the Company. “The culmination of many milestones from cultivation, engineering, extraction and sales are blending harmoniously into Q4. I am very proud of my team’s accomplishments as we enter this new phase of our journey, of seed to CBD. Our progress clearly defines Stillcanna as one of the leaders in the space.”
On Behalf of the Board
Jason Dussault, CEO
CONTACT:
Mauricio Inzunza
[email protected]
1(844)-442-STILL (7845)
Cautionary Note Regarding Forward Looking Statements: This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including that the Company expects that the Nexus extraction facility in Poland will begin processing its 2019 harvest in Q4 to begin fulfilling its CBD delivery contracts. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should" or "would" occur. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the Nexus extraction facility in Poland will begin processing its 2019 harvest in Q4 to begin fulfilling its CBD delivery contracts. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, that the Nexus extraction facility in Poland will not begin processing its 2019 harvest in Q4 or at all and will not begin fulfilling its CBD delivery contracts. Readers are cautioned not to place undue reliance on forward-looking statements. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
SOURCE: Stillcanna Inc.